Fig. 1 | Cellular & Molecular Immunology

Fig. 1

From: A de novo missense mutation in MPP2 confers an increased risk of Vogt–Koyanagi–Harada disease as shown by trio-based whole-exome sequencing

Fig. 1

Identification of de novo mutations for VKH disease. A Identification of the de novo MPP2 p.K315N mutation in one VKH trio family. B The predicted conservation for the MPP2-K315N mutation in humans, Rhesus monkeys, mice, etc. C The structure prediction of the MPP2-K315 and MPP2-N315 proteins. D The expression profile of the MPP2 gene in several human tissues and cell lines. E The nTPM of MPP2 in immune cells. F The expression levels of MPP2 in B cells, DC cells, RPE cells and T cells

Back to article page